Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
about
Ocular surface squamous neoplasia - Review of etio-pathogenesis and an update on clinico-pathological diagnosisPrevalence and Severity of Ocular Surface Neoplasia in African Nations and Need for Early InterventionsSurgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.Clinical outcome of advanced squamous cell carcinoma of the conjunctiva.Topical interferon alpha-2b for treatment of noninvasive ocular surface squamous neoplasia with 360° limbal involvement.Superficial ocular malignancies treated with strontium-90 brachytherapy: long term outcomesSurgical versus Medical Treatment of Ocular Surface Squamous Neoplasia: A Cost Comparison.Interferon alpha-2b in giant ocular surface squamous neoplasia.Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.Tumors of the ocular surface: A review.Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia: A Literature-Based Decision Analysis.Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity.Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?Immunoreduction of locally advanced orbito-conjunctival squamous cell carcinoma with intraorbital interferon alpha-2b injection: a globe saving approach.Amniotic membrane transplantation with topical interferon alfa-2b after excision of ocular surface squamous neoplasia.Widespread Ocular Surface Squamous Neoplasia Treated with Topical Interferon Alpha-2b
P2860
Q22251452-AEE516CC-941F-412B-9432-A03F099D4B17Q28077525-EA1B9ED8-3918-4575-904A-737B719D78F5Q33573942-F10EFA7C-306C-42D3-8F28-A3B9C6922737Q34055087-596B3382-00FE-4D7F-8FE5-2E5D909154F6Q35087010-C984533C-3EDF-4C87-BE85-D450EDC4513BQ36328586-BA7657DD-DA3C-4374-9DA4-E8C795F430F4Q37130876-F4701AA2-9787-460F-94DA-07397509EC10Q37138033-AC8F355E-1468-433C-96B9-739CF2C0D927Q37517721-2D987670-C248-43C4-A9A1-C376FF2E9652Q38477793-06E0CA38-0BC6-4EB7-A99A-209935066DD5Q38906443-001FF46C-2090-4E4E-B5FD-A7E661D5C3A3Q41634028-C7462A18-873B-4E19-9D15-1317B315F6FBQ44301436-90B7D049-B0DC-4A4D-A635-C29489025780Q47559618-B3022F38-9EAA-4BE6-BAF5-9B1172F073FDQ48342784-FFE9734B-BEB6-4CF2-B95A-DA8D717DC1ABQ49270882-1FF2A9F6-70F1-4C28-82A2-B164B6162219Q57494847-2E608E5B-2CBB-4043-933D-DE5D074643A4
P2860
Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Giant ocular surface squamous ...... unotherapy or immunoreduction.
@en
Giant ocular surface squamous ...... unotherapy or immunoreduction.
@nl
type
label
Giant ocular surface squamous ...... unotherapy or immunoreduction.
@en
Giant ocular surface squamous ...... unotherapy or immunoreduction.
@nl
prefLabel
Giant ocular surface squamous ...... unotherapy or immunoreduction.
@en
Giant ocular surface squamous ...... unotherapy or immunoreduction.
@nl
P2093
P1433
P1476
Giant ocular surface squamous ...... unotherapy or immunoreduction.
@en
P2093
Carol L Shields
H Jane Kim
Sara E Lally
Swathi Kaliki
P304
P356
10.1016/J.OPHTHA.2011.11.035
P577
2012-02-22T00:00:00Z